ARTICLE
5 March 2020

Opioid Defendants Appeal Judge's Ruling On Trial Structure

CC
Clyde & Co

Contributor

Clyde & Co is a leading, sector-focused global law firm with 415 partners, 2200 legal professionals and 3800 staff in over 50 offices and associated offices on six continents. The firm specialises in the sectors that move, build and power our connected world and the insurance that underpins it, namely: transport, infrastructure, energy, trade & commodities and insurance. With a strong focus on developed and emerging markets, the firm is one of the fastest growing law firms in the world with ambitious plans for further growth.
The court overseeing statewide opioid litigation in New York recently made a ruling regarding the manner in which a March 2020 trial will proceed.
United States Litigation, Mediation & Arbitration

The court overseeing statewide opioid litigation in New York recently made a ruling regarding the manner in which a March 2020 trial will proceed.

The court overseeing statewide opioid litigation in New York recently made a ruling regarding the manner in which a March 2020 trial will proceed on liability for New York State entities' public nuisance claims against manufacturers and sellers of opioid products. On February 14, 2020, Judge Jerry Gargiulo denied the opioid defendants' request for a unified trial, while also allowing for certain portions of defendants' medical causation defenses to be heard during the trial's liability portion. A copy of the order and defendants' notice of appeal can be accessed here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More